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Previously we have shown that human platelets release u-6-L-fucosyltransferase (EC 2.4.1.68) during coagulation of 
blood [(1987) Glycoconjugate J. 4, 43491. Here we report that agonists which induce platelet aggregation bring about 
release of the enzyme. In quantitative terms the release of a-6-L-fucosyltransferase bywashed, aggregated platelets was 
very similar to that occurring during blood coagulation. 
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1. INTRODUCTION 
Recently we have shown that serum a-6-L- 
fucosyltransferase (EC 2.4.1.68) originates from 
platelets to an extent of 90% [1,2]. The enzyme is 
released from platelets during coagulation of 
blood. In contrast, serum a-3-L-fucosyltransferase 
(EC 2.4.1.52) does not originate from platelets 
[2,3]. Here, we report that o-6-L-fucosyltranferase 
is liberated by agonists which cause platelets to 
change shape, aggregate, and secrete. 
2. MATERIALS AND METHODS 
2.1. Chemicals and reagents 
GDP-[‘4C]fucose (200 mCi/mmol) and [‘Hlserotonin 
(creatinine sulphate) (10 Ci/mmol) were purchased from the 
Radiochemical Centre (Amersham, England), ADP from 
Reanal (Hungary), ristocetin sulphate from H. Lundbeck 
(Copenhagen), adrenalin from Polfa (Warsaw), human 
fibrinogen from Kabi (Sweden), bovine thrombin from Biomed 
(Lublin, Poland) and collagen from Sigma. Other chemical 
reagents were from standard commercial sources. 
2.2. Preparation of washed platelets 
Blood withdrawn from regular blood donors was collected in- 
to l/l0 vol. of 3.8% sodium citrate. Platelets were isolated by 
the method of Mustard et al. [4] but the first washing solution 
contained 2 mM NazEDTA instead of heparin. The concentra- 
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tion of apyrase amounted to 50 mg/l. Following washings the 
platelets were suspended in solution A. 
2.3. Labelling of platelets with [3H]serotonin 
Labelling was essentially according to [5]. Briefly, titrated 
platelet-rich plasma (PRP, 15 ml) was treated with 130~1 of 
10 PM serotonin in 0.15 M NaCl. Following incubation at 37°C 
for 40 min with occasional stirring the platelets were isolated as 
described [4]. 
2.4. Aggregation of platelets and release reaction 
Portions of washed platelets (1 ml) were treated with 100~,ul 
aliquots of aggregating agents and incubated at 37°C for 
15 min with continuous stirring. The reaction was stopped by 
transferring the samples to an ice bath. Thereafter, the samples 
were centrifuged in a refrigerated centrifuge and the super- 
natants assayed for cu-6-L-fucosyltransferase activity. If 
[‘Hlserotonin-labelled platelets were used portions of the same 
supernatants were tested for radioactivity by liquid scintillation 
counting. Agonists employed and their final concentrations 
were: ADP (20cM), with fibrinogen (1 mg/ml); collagen 
(0.2 mg/ml); adrenalin (50 pmol/ml); ristocetin (1.5 mg/ml); 
thrombin (0.4 U/ml or as indicated in section 3). In all ex- 
periments fractions of enzyme activities released were 
calculated relative to total enzyme activities determined in 
Triton X-100 lysates of platelets. Changes in light transmission 
were recorded in a model 169 aggregometer (Evans Electronic). 
2.5. a-6-L-Fucosyltransferase 
The enzyme activity was determined essentially as in [2] but 
using another batch of substrate (stripped IgG glycopeptide) 
and a simplified technique for product isolation. Incubation 
mixtures contained, in 29.25 ~1: 25 ,ug IgG glycopeptide, 1 rmol 
Na-cacodylate buffer (pH 6.0), 0.2pmol EGTA, 0.2cmol 
MgCl2,61 pmol GDP-[‘4C]fucose, 6 ~1 serum or supernatant of 
aggregated platelets. When washed platelets were assayed for 
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enzyme activity they were lysed beforehand with 0.5% final 
concentration of Triton X-100. After 2 hat 37°C reactions were 
terminated by addition of 5 ~1 of 0.2 M EDTA. Aliquots were 
then directly spotted on DE-81 Whatman paper and separated 
by descending chromatography with water. The solvent was 
allowed to run to a distance of 16 cm from the starting line 
(marked previously with pencil). Thereafter, the papers were 
dried and developed once again with methanol/ethanol (3 : 2, 
v/v) down to 26 cm from the start. Radioactivity present on 
four 1 x 4 cm adjacent paper strips at 15-19 cm from the start- 
ing line was determined by liquid scintillation counting. 
3. RESULTS 
Table 1 lists the effects of different aggregating 
and activating agents upon release of a-6-L- 
fucosyltransferase from isolated platelets. All 
agonists brought about significant liberation of the 
enzyme. Blood donors for these experiments were 
preselected so that their platelets gave a good 
response to 20pM ADP in the presence of 
1 mg/ml fibrinogen as recorded by the ag- 
gregometer (minimum 20% change in light 
transmission at 20 s after addition of aggregant). 
Platelets from donor 4 were treated with graded 
Table 1 
Release of cu-6-L-fucosyltransferase activity (Ftr) by activated 
platelets 
Donor 
1 2 3 4 5 
Platelet count in blood 
xl000 284 218 370 nd nd 
Platelet count in washed 
platelets x 1000 213 240 410 672 668 
FTr in serum 1.2 1.05 4.45 nd nd 
FTr in washed platelets 
dissolved in 0.5% 
Triton X-100 2.5 2.45 6.05 2.65 3.2 
Release (%) by: 
Thrombin 22.7 24.9 43.5 28.7 37.9 
(58.1) (23.7) (64.7) 
Collagen 25.7 23.5 48.2 35.6 51.9 
(62.1) (99.0) (46.1) 
ADP 2.6 4.8 4.8 11.9 44.6 
Adrenalin nd nd nd 18.8 42.3 
Ristocetin nd nd nd 14.3 46.2 
Enzyme activity expressed as pmol [‘4C]fucose incorporated 
into stripped IgG glycopeptide/pl per h. % release of enzyme 
activity was calculated relative to the total enzyme activity in 
washed platelets, dissolved in 0.5% Triton X-100; values in 
parentheses show % release of [‘Hlserotonin; nd, not 
determined 
concentrations of thrombin, i.e. 0.08, 0.16, 0.4 
and 5.0 U/ml. The response of platelets was dose- 
dependent and amounted to 15.6, 21.8, 28.7 and 
28.1%, respectively, of the enzyme liberated. A 
similar experiment performed on platelets of 
donor 5 revealed that 5.0 U/ml of thrombin 
brought about the release of more enzyme (62.3%) 
than the standard concentration of 0.4 U/ml (see 
table 1). The data in table 1 plus plasma enzyme 
activity (not shown) also allow one to calculate the 
extent of enzyme released during coagulation of 
blood. Thus, after 30 min incubation of whole 
blood at 37”C, platelets of donors l-3 released 
17.8, 23.3 and 41.1%, respectively, of the total en- 
zyme present in washed platelets. In the calculation 
corrections were made for the partial volume of 
erythrocytes in blood samples taken for prepara- 
tion of the sera (during coagulation of blood the 
enzyme is released into a smaller volume than in 
the aggregated platelet concentrate), the enzyme 
present in blood plasma outside platelets, and dif- 
ferent counts of platelets in blood and washed 
platelet concentrates. 
4. DISCUSSION 
cu-6-L-Fucosyltransferase is the enzyme of 
glycoprotein biosynthesis which conveys L-fucose 
in al-6 glycosidic linkage to asparagine-linked N- 
acetylglucosamine residues of N-glycans [6]. The 
resulting structure . . GlcNA@l-4[Fuc~l-6]GlcN- 
Ac,f31-4-N-Asn-R. is present in the GPIIb-IIIa 
complex on the platelet surface [7]. The complex is 
an integrin for fibrinogen, von Willebrand factor 
and fibronectin but does not bind the ligands in 
unstimulated platelets [8]. Although limited in 
number, our experiments how quite clearly that 
the aggregated platelets release ad-l-fucosyltrans- 
ferase. Thrombin and collagen were good inducers 
of enzyme release while ADP was the least effec- 
tive. The latter produced a good response only 
from platelets of donor 5. Under conditions of 
blood coagulation the release of ad-l-fucosyl- 
transferase into blood serum was quite similar to 
that caused by the action of either thrombin or col- 
lagen upon isolated platelets. Previously we have 
shown that the soluble a-6-L-fucosyltransferase 
activity peaks at 15 min when PRP is recalcined 
and subsequently incubated at 37°C [9]. The 
released enzyme was in a true soluble form and did 
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not sediment after centrifugation of serum at 
100000 x g for 60 min. As shown in this paper 
thrombin at 0.08 U/ml, i.e. a concentration which 
produces only a transient, reversible aggregation 
of platelets, brings about significant release of the 
enzyme. 
Superficially, liberation of cu-6-L-fucosyltrans- 
ferase from platelets by different agonists 
resembles the release reaction in which low- and 
high-n/l, materials contained in a soluble form in 
platelet granules are secreted. This similarity may 
be misleading. Although glycosyltransferases are 
present in a soluble form in blood serum and other 
body fluids, these enzymes are located primarily 
within cells and are membrane-bound. 
Recently, it has been shown that rat liver 
cu-2,6_sialyltransferase (EC 2.4.99.1) is solubilized 
by proteolytic cleavage between membrane- 
binding and catalytic domains [lo]. It is well 
known that the aggregation of platelets is accom- 
panied by the activation of endogenous proteases 
(calpains) [ll]. Thus, the release of a-6-L- 
fucosyltransferase from platelets may result either 
from secretion of a soluble enzyme contained 
within granules or proteolysis of a membrane- 
bound form or both. Experimental distinction be- 
tween these mechanisms may be difficult. 
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